Everycell's Effect on DNA Damage, Inflammation, and Stress
Completed · Not applicable · Has a placebo group
Conditions studied: Family Member
In brief
The investigators are conducting this research because they want to determine if a dietary supplement, called Everycell™, has an effect on the functioning of the study participants' cells. The results of this research will be used to help develop additional strategies for trying to fight the effects of aging. The primary purpose of this study is to determine the effectiveness of Everycell™ compared to placebo (a pill that does nothing) on DNA damage, inflammation, stress, and related factors. Taking Everycell™ is not a medical prescription, treatment, or cure for any known disease or condition. Helping patients' nutritional status is important to prevent the continued worsening of chronic diseases and also to counteract the effects of aging. Americans also have difficulties with compliance to prescription medications due to their toxicity and side effects. This study aims to learn more about how a dietary supplement may improve nutritional status and enable the body to normalize cellular functioning, which may improve quality of life. The results of this research will be used to determine if Everycell™ is beneficial for overall cellular health and to counteract the effects of aging.
Key facts
- Study ID
- NCT02032693
- Run by
- University of Miami
- People needed
- 30
- Starts
- 2013-12-01
- Expected to finish
- 2014-04-01
- Last updated by the study team
- 2014-05-23
Who can join
Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Be between the ages of 18 and 55
- Live independently without medical assistance
- Willing to provide informed consent to participate in the study
- Willing to follow our procedures and requirements for the study, including:
- providing blood, urine, and saliva samples
- completing other assessments
- Patients may take a similar dietary supplement as the one used in the study, but they must stop taking all similar dietary supplements 2 weeks prior to starting the study and for the 6 weeks duration of the study.
You may not qualify if…
- Patients need to be free of major medical conditions, such as neurological, cardiovascular, pulmonary, renal, endocrine, thyroid, hepatic, autoimmune, or bone/joint disorders or conditions; psychiatric diagnoses or psychotic disorders, and have no gastrointestinal disorders that could affect how the dietary supplement is absorbed by their body.
- Cannot participate in another similar research trial within 30 days of participating in this study
- Cannot be a smoker or have stopped smoking less than 6 months ago
- Cannot currently be taking any chemotherapy or radiation treatment for cancer
- Cannot be diagnosed with a terminal illness
- Cannot be diagnosed with insulin-dependent diabetes and/or be taking metformin
- Cannot be HIV positive
- If female, the patient cannot currently be pregnant, breastfeeding, or intending to become pregnant within the next month
Where it is running
- University of Miami Miller School of Medicine, Clinical Research Building — Miami, Florida, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.